Axxam being one of the pioneers in the application of optogenetics in the early phases of the drug discovery process, we are very proud to be part of the 3rd International Conference on Photopharmacology exploring the relationship between photopharmacology and optogenetics, as they not only share similar challenges but also the aim to find innovative solutions and therapies for human medicine.

Don’t miss the talk of Viviana Agus (one of Axxam’s Cell Biology unit managers) entitled “Optogenetics, an innovative approach in drug discovery”, to be held on 29th November at 15.50 CET.